288 related articles for article (PubMed ID: 27897407)
1. Activin A induces skeletal muscle catabolism via p38β mitogen-activated protein kinase.
Ding H; Zhang G; Sin KW; Liu Z; Lin RK; Li M; Li YP
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):202-212. PubMed ID: 27897407
[TBL] [Abstract][Full Text] [Related]
2. Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2.
Zhang G; Lin RK; Kwon YT; Li YP
FASEB J; 2013 Jul; 27(7):2893-901. PubMed ID: 23568773
[TBL] [Abstract][Full Text] [Related]
3. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting.
Zhang G; Jin B; Li YP
EMBO J; 2011 Aug; 30(20):4323-35. PubMed ID: 21847090
[TBL] [Abstract][Full Text] [Related]
4. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.
Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP
Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181
[TBL] [Abstract][Full Text] [Related]
5. Myostatin is a novel tumoral factor that induces cancer cachexia.
Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
[TBL] [Abstract][Full Text] [Related]
6. p38β MAPK upregulates atrogin1/MAFbx by specific phosphorylation of C/EBPβ.
Zhang G; Li YP
Skelet Muscle; 2012 Oct; 2(1):20. PubMed ID: 23046544
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of activins promotes muscle wasting and cachexia.
Chen JL; Walton KL; Winbanks CE; Murphy KT; Thomson RE; Makanji Y; Qian H; Lynch GS; Harrison CA; Gregorevic P
FASEB J; 2014 Apr; 28(4):1711-23. PubMed ID: 24378873
[TBL] [Abstract][Full Text] [Related]
8. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 stimulates catabolism in C2C12 myotubes.
Li W; Moylan JS; Chambers MA; Smith J; Reid MB
Am J Physiol Cell Physiol; 2009 Sep; 297(3):C706-14. PubMed ID: 19625606
[TBL] [Abstract][Full Text] [Related]
10. Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90.
Wu HY; Trevino JG; Fang BL; Riner AN; Vudatha V; Zhang GH; Li YP
Cells; 2022 Sep; 11(17):. PubMed ID: 36078164
[TBL] [Abstract][Full Text] [Related]
11. Activin A induction of erythroid differentiation through MKK6-p38alpha/p38beta pathway is inhibited by follistatin.
Huang HM; Li YC; Chung MH
J Cell Physiol; 2010 Jun; 223(3):687-94. PubMed ID: 20162623
[TBL] [Abstract][Full Text] [Related]
12. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
13. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
[TBL] [Abstract][Full Text] [Related]
14. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
Yang W; Chen Y; Zhang Y; Wang X; Yang N; Zhu D
Cancer Res; 2006 Feb; 66(3):1320-6. PubMed ID: 16452185
[TBL] [Abstract][Full Text] [Related]
15. The role of myostatin and activin receptor IIB in the regulation of unloading-induced myofiber type-specific skeletal muscle atrophy.
Babcock LW; Knoblauch M; Clarke MS
J Appl Physiol (1985); 2015 Sep; 119(6):633-42. PubMed ID: 26205544
[TBL] [Abstract][Full Text] [Related]
16. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
[TBL] [Abstract][Full Text] [Related]
17. Activin A induces tumorigenesis of leiomyoma via regulation of p38β MAPK-mediated signal cascade.
Bao H; Sin TK; Zhang G
Biochem Biophys Res Commun; 2020 Aug; 529(2):379-385. PubMed ID: 32703439
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38β to proapoptotic p38α.
Ferrari G; Terushkin V; Wolff MJ; Zhang X; Valacca C; Poggio P; Pintucci G; Mignatti P
Mol Cancer Res; 2012 May; 10(5):605-14. PubMed ID: 22522454
[TBL] [Abstract][Full Text] [Related]
20. Mice overexpressing growth hormone exhibit increased skeletal muscle myostatin and MuRF1 with attenuation of muscle mass.
Consitt LA; Saneda A; Saxena G; List EO; Kopchick JJ
Skelet Muscle; 2017 Sep; 7(1):17. PubMed ID: 28870245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
